1Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses[ J ]. Annu Rev Immunol, 1998,16 :225-260.
2Eyndhoven WG, Garrrper CJ, Cho E, et al. TRAF-3 mRNA splice-deletion variants eneord isoforms that induce NF-kaptm B activation [ J ] .Mol Immunol, 1999,36(10) : 647-658.
3Chen F, Castranova V, Shi X, et al. New insights into the role of nuclear factor-Kappa B,a ubiquitous transcription factor in the initiation of diseases[J]. Clin Chem, 1999,45( 1 ) :7-17.
4Seko Y, Takahashi N, Yagila H, et al. Expression of cytokine mRNA in murine hearts with acute myocarditis caused by coxsackievirus B3 [ J ]. J Pathol, 1997,183( 1 ) : 105-108.
5Christman JW, Lancaster IM, Blackwell TS. Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy [ J ]. Intensive Care Med, 1998,24 ( 11 ) : 1131-1138.
6Matsumori A, Nunokawa Y, Yamaki A, et al. Suppression of cytokines and nitric oxide production, and protection against lethal endotoxemia and viral myocarditis by a new NF-KappaB inhibitor[J]. Eur J Heart Fail, 2004,6(2): 137-144.
7Yokoseki O, Suzuki J, Kitabayashi H, et al. Cis Element decoy against nuclear factor-KappaB attenuates development of experimental autoimmune myocarditis in rats[J]. Circ Res,2001 ;89(10) :899-906.
8Creagh EM, Conroy H, Martin SJ. Caspase-activation pathyways in apoptosis and immunity[J]. Immunol Rev,2003,193 : 10-21.
9Seko Y, Kayagaki N, Seino K, et al. Role of Fas/FasL pathway in the activation of infiltrating cells in routine acute myocarditis caused by Coxsackievirus B3[J] .J Am Coll Cardiol,2002,39(8) : 1399-1403.
10Bennett R. Apoptosis in the cardiovascular system[ J ]. Heart, 2002, 87 (5):480-487.
10[6]Chen F,Castranova,V,Shi X,et al.New insights into the role of nuclear factor-kappa B,a ubiquitous transcription factor in theinitiation of diseases[J].Clin Chem,1999,45(1):7-17.
